ALOXI 250 micrograms, solution for injection bottle, 5 ml
Active ingredients: (3aS)-palonosetron hydrochloride, (3aS)-palonosetron
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALOXI 250 microgrammes, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 5 ml
- Marketing authorisation holder
- HELSINN BIREX PHARMACEUTICALS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Dec 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61794949CIP73754828CIP133400937548281Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PALONOSÉTRON (CHLORHYDRATE DE)solution | — | SA |
| PALONOSÉTRON BASEsolution | 50 microgrammes · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.